NorthRock Partners’s Organon & Co OGN Stock Holding History

NorthRock Partners’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-10,773	Closed	-$115K	–	831
2025 Q3	$115K	Buy	+10,773	New	+$106K	﹤0.01%	841

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PMG

Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

KBG

Kahn Brothers Group New York $633M AUM 39.01% 1-Year Est. Return

NorthRock Partners's OGN Position: Q4 2025 in Review

NorthRock Partners sold out of Organon & Co (OGN) in Q4 2025, closing a stake of 10,773 shares — an estimated $115K sold.

NorthRock Partners first reported a position in OGN in Q3 2025 and held it in 1 quarter. The position peaked at $115K in Q3 2025. 634 funds tracked by Wall St. Rank hold OGN as of Q4 2025.

NorthRock Partners reported no remaining Organon & Co position as of Q4 2025 after selling out during the quarter.
NorthRock Partners sold 10,773 Organon & Co shares in Q4 2025, an estimated $115K.
NorthRock Partners first reported a position in Organon & Co in Q3 2025 and held it in 1 quarter.
NorthRock Partners's Organon & Co position peaked at $115K in Q3 2025.
634 funds tracked by Wall St. Rank held Organon & Co as of Q4 2025.

Based on NorthRock Partners's 13F filing for Q4 2025, filed 17 Feb 2026.